ArticleFrontiers in genetics2023
Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Impact of the Interprofessional Collaborative Education Program (IPCEP) on the knowledge, attitudes, and practices of diabetic foot care among individuals with type 2 diabetes mellitus: a narrative review.BMC health services research · 2025Pooled it
- Sickle cell retinopathy in Africa: a systematic review and meta-analysis.Scientific reports · 2026Article
- Analgesic Utilization Pattern and Cost of Managing Children with Sickle Cell Diseases: a Retrospective Single-site Audit.Journal of racial and ethnic health disparities · 2026Article
- From policy to practice: World Health Organization's contribution to safer blood transfusions in Africa for sickle cell management - a review.Annals of medicine and surgery (2012) · 2026Review
- Integration of newborn screening for sickle cell disease into primary health care in Bukavu, Democratic Republic of the Congo: a pilot study.BMC primary care · 2025Article
- Article
- Barriers and facilitators to implementing a task-sharing mental health intervention for Sickle Cell Disease populations in low- and middle-income countries: a qualitative analysis using the Consolidated Framework for Implementation Research (CFIR).Frontiers in public health · 2025Article
- Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.Frontiers in health services · 2025Article
- Looking ahead: ethical and social challenges of somatic gene therapy for sickle cell disease in Africa.Gene therapy · 2024Review
- Integrating comprehensive care in the management of sickle cell disease patients in Nigeria.Hematology, transfusion and cell therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors at 20 institutions in 1 country.
Hezekiah IsaCentre of Excellence for Sickle Cell Research and Training, University of Abuja (CESRTA) Federal Capital Territory (FCT), Abuja, Nigeria.
Emmanuel OkochaDepartment of Haematology, Nnamdi Azikiwe University Teaching Hospital Nnewi, Nnewi, Anambara State, Nigeria.
Samuel Ademola AdegokeDepartment of Paediatrics and Child health, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria.
Uche Nnebe-AgumaduDepartment of Paediatrics, University of Abuja Teaching Hospital, Abuja, Nigeria.
Aisha Kuliya-GwarzoDepartment of Haematology, Aminu Kano University Teaching Hospital, Kano, Kano State, Nigeria.
Alayo SopekanNon Communicable Disease Unit, Federal Ministry of Health, Federal Secretariat, Abuja, Nigeria.
Akinyemi Olugbenga OfakunrinDepartment of Paediatrics, Jos University Teaching Hospital, Jos, Nigeria.
Ngozi UgwuDepartment of Haematology, Alex Ekweme Federal Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.
Abdul-Aziz HassanDepartment of Haematology and Blood Transfusion, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.
Chinatu OhiaeriDepartment of Paediatrics, Federal Medical Centre Keffi, Keffi, Nasarawa State, Nigeria.
Anazoeze MaduDepartment of Haematology, University of Nigeria Teaching Hospital, Enugu, Enugu State, Nigeria.
Ijeoma Diaku-AkinwumiDepartment of Paediatrics, Lagos State University Teaching Hospital, Ikeja, Lagos State, Nigeria.
Lilian EkwemDepartment of Paediatrics, General Hospital Nyanya, Abuja, Nigeria.
Livingstone Gayus DogaraDepartments of Haematology and Blood Transfusion, Kaduna State University Teaching Hospital, Kaduna, Kaduna State, Nigeria.
Dorothy OkohDepartment of Haematology, Rivers State University, Port Harcourt, Rivers State, Nigeria.
James JasiniDepartment of Haematology, Federal Medical Centre, Yola, Adamawa State, Nigeria.
Ahmed GireiDepartment of Haematology, Federal Teaching Hospital Gombe, Gombe, Gombe State, Nigeria.
Timothy EkwereDepartment of Haematology, University of Uyo, Uyo, Akwa IbomState, Nigeria.
Angela OkoloFederal Medical Centre Asaba, Asaba, Delta State, Nigeria.
Umar KangiwaDepartment of Haematology, Federal Medical Centre, Birnin Kebbi, Kebbi State, Nigeria.
Juliet LawsonDepartment of Paediatrics, Zankli Medical Centre, Abuja, Nigeria.
Reuben ChianumbaCentre of Excellence for Sickle Cell Research and Training, University of Abuja (CESRTA) Federal Capital Territory (FCT), Abuja, Nigeria.
Biobele BrownDepartment of Paediatrics, University College Hospital, Ibadan, Oyo State, Nigeria.
Norah AkinolaDepartment of Haematology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Osun State, Nigeria.
Maxwell NwegbuCentre of Excellence for Sickle Cell Research and Training, University of Abuja (CESRTA) Federal Capital Territory (FCT), Abuja, Nigeria.
Obiageli NnoduCentre of Excellence for Sickle Cell Research and Training, University of Abuja (CESRTA) Federal Capital Territory (FCT), Abuja, Nigeria.
University of Abuja · NGFederal Medical Centre · NGObafemi Awolowo University · NGAhmadu Bello University · NGAminu Kano Teaching Hospital · NGFederal Medical Centre · NGFederal Medical Centre · NGFederal Ministry of Health · NGFederal Teaching Hospital Abakaliki · NGGombe State University · NGJos University Teaching Hospital · NGKaduna State University · NGLagos State University Teaching Hospital · NGNational Hospital Abuja · NGNnamdi Azikiwe University Teaching Hospital · NGRivers State University · NGUniversity College Hospital, Ibadan · NGUniversity of Nigeria Teaching Hospital · NGUniversity of Uyo · NGZankli Medical Centre · NG
Funding
Sickle Pan African Research Consortium NigEria (SPARC-NEt)U01HL156942 · NHLBI · UNIVERSITY OF ABUJA · PI NNODU, OBIAGELI EUNICE · 2021 to 2025
$1.3MNHLBI NIH HHS U01 HL156942
Abstract
PubMed holds no abstract for this paper.
Indexed as
healthcare servicesNigeriasickle cell diseasesickle cell disease networkstakeholder engagement
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.